Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2016-07-01
Summary
Analysis of exhaled breath condensate biomarkers and cough severity in patients with idiopathic pulmonary fibrosis.
Conditions
Sponsors & Collaborators
-
University of East Anglia
lead OTHER
Principal Investigators
-
Andrew M Wilson, MD MRCP · University of East Anglia
-
Christopher Atkins, MBBS · University of East Anglia
-
Ashnish Sinha · University of East Anglia
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease
NCT05214508 ·Status: COMPLETED ·Phase: NA
-
The Role of Computed Tomography in the Phenotyping of COPD Patients
NCT05747235 ·Status: COMPLETED
-
Dyspnea and Idiopathic Pulmonary Fibrosis
NCT04864990 ·Status: COMPLETED
-
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
NCT00655694 ·Status: WITHDRAWN
-
Breath Analysis in Lung Fibrosis
NCT02437448 ·Status: COMPLETED
-
Idiopathic Pulmonary Fibrosis Registry China Study
NCT03666234 ·Status: UNKNOWN
-
PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT
NCT05609201 ·Status: ENROLLING_BY_INVITATION
-
Immunopathologic Profiles and Blood Biomarkers in Patients With IPF
NCT04187079 ·Status: COMPLETED
-
Prevalence of Bronchiectasis in COPD Patients
NCT04101448 ·Status: UNKNOWN
-
Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions
NCT04987606 ·Status: COMPLETED
-
Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study
NCT02076061 ·Status: COMPLETED
-
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
NCT00394940 ·Status: COMPLETED
-
The Oxidative Stress, Inflammatory Markers, and Metabolomics Response to Exercise in Patients With COPD
NCT04117412 ·Status: COMPLETED ·Phase: NA
-
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
NCT01874223 ·Status: COMPLETED
-
Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema
NCT01121367 ·Status: COMPLETED
-
Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled Study
NCT05157204 ·Status: UNKNOWN
-
Biomarkers for Diagnosis and Treatment of COPD
NCT02633280 ·Status: COMPLETED
-
Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK
NCT02468271 ·Status: COMPLETED
-
Impact of COVID-19 on Lung Function in COPD Patients.
NCT05770440 ·Status: RECRUITING
-
Cohort of IPF Patients Experiencing an Exacerbation
NCT04442711 ·Status: RECRUITING
-
Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis
NCT03643263 ·Status: COMPLETED
-
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876 ·Status: RECRUITING
-
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
NCT00373841 ·Status: RECRUITING